Cipla | CIPLA - Operating Profit

Stock Price
1,317.80
Daily Change
-23.30 -1.74%
Monthly
0.37%
Yearly
-10.76%
Q1 Forecast
1,315.62

Cipla reported INR9.77B in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Arca Biopharma USD -25.09M 5.23M Mar/2025
aTyr Pharma USD -26.74M 6.43M Sep/2025
Bio Path USD -3.24M 616K Mar/2025
Brainstorm Cell Therapeutics USD -3.09M 100K Mar/2025
Capricor Therapeutics USD -24.98M 17.28M Mar/2025
Cara Therapeutics USD -2.39M 3.49M Mar/2025
Cipla INR 9.77B 6.21B Dec/2025
Dr.Reddys Laboratories INR 13.94B 2.31B Dec/2025
Esperion Therapeutics USD -16.03M 18.6M Sep/2024
Immunic USD -25.73M 2.91M Sep/2024
Infinity Pharmaceuticals USD -10.12M 1.39M Jun/2023
Minerva Neurosciences USD -21.85M 17.48M Dec/2024
Nektar Therapeutics USD -34.34M 15.43M Sep/2024
Sangamo BioSciences USD -33.51M 12.77M Jun/2024
Sun Pharmaceuticals INR 33.67B 49.9M Sep/2025
TherapeuticsMD USD -1.18M 40K Jun/2024
UPL INR 16.06B 1.72B Dec/2025